EUVIMEDEUVIMED entdecken
Editorial

Editorial: Personalising the Low FODMAP Diet to Achieve Therapeutic Benefit Whilst Reducing Burden and Maintaining Dietary Diversity in Irritable Bowel Syndrome. Authors' Reply

E Coss-Adame iD, M F Garcia-Cedillo, M F Huerta-de la Torre, J S Arenas-Martinez

Alimentary Pharmacology & Therapeutics · 2026-06 · 63 (11) · 1559-1560

DOI: 10.1111/apt.70631 ↗

Kurz gefasst

Editorial in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 25.03.2026. Verfasst von E Coss-Adame und 3 weiteren Autor:innen. Beteiligte Einrichtung: Gastrointestinal Motility Laboratory, Department of Gastroenterology, Instituto Nacional de Ciencias Medicas y Nutricion "Salvador Zubiran", Mexico C…. Die Arbeit nennt 6 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Gastrointestinal Motility Laboratory, Department of Gastroenterology, Instituto Nacional de Ciencias Medicas y Nutricion "Salvador Zubiran", Mexico City, Mexico.

ORCID-Profile: E Coss-Adame

Zitieren

APA

Coss-Adame, E., Garcia-Cedillo, M. F., Huerta-de la Torre, M. F., & Arenas-Martinez, J. S. (2026). Editorial: Personalising the Low FODMAP Diet to Achieve Therapeutic Benefit Whilst Reducing Burden and Maintaining Dietary Diversity in Irritable Bowel Syndrome. Authors' Reply. Alimentary Pharmacology & Therapeutics, 63(11), 1559-1560. https://doi.org/10.1111/apt.70631

Vancouver

Coss-Adame E, Garcia-Cedillo MF, Huerta-de la Torre MF, Arenas-Martinez JS. Editorial: Personalising the Low FODMAP Diet to Achieve Therapeutic Benefit Whilst Reducing Burden and Maintaining Dietary Diversity in Irritable Bowel Syndrome. Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026;63(11):1559-1560. doi:10.1111/apt.70631

BibTeX
@article{CossAdame2026,
  author = {Coss-Adame, E and Garcia-Cedillo, M F and Huerta-de la Torre, M F and Arenas-Martinez, J S},
  title = {Editorial: Personalising the Low FODMAP Diet to Achieve Therapeutic Benefit Whilst Reducing Burden and Maintaining Dietary Diversity in Irritable Bowel Syndrome. Authors' Reply},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {63},
  number = {11},
  pages = {1559--1560},
  doi = {10.1111/apt.70631}
}
Kostenlos starten →